PMID: 2496420Jan 1, 1989Paper

Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks

Psychopharmacology
F R Snyder, J E Henningfield

Abstract

The purpose of this study was to assess the effects of acute nicotine administration, following a 12-h cigarette deprivation period, using a computerized performance assessment battery (PAB). The PAB was comprised of five tasks which were selected to reflect a variety of complex acquired behaviors, sometimes referred to as "cognitive performance". Subjects were six healthy, male, cigarette smokers who practiced on the approximately 15 min PAB until their performance was stable across trials. In the training and baseline phase, subjects were tested following 5-30 min deprivation of cigarettes. Subjects were then tested following 12 h cigarette deprivation; 20 min before these sessions, subjects were given one piece of gum to chew. The gum contained 0, 2, or 4 mg nicotine, and it was chewed for 10 min at a rate of one chew every 2 s. There were two main findings: (1) when placebo (0 mg) gum was given, the time taken to complete the PAB tasks was significantly elevated above values obtained in the baseline condition; (2) compared to placebo, nicotine administration produced a dose-related decrease in the time taken to complete the tasks such that with either 2 or 4 mg, performance time was similar to that which occurred in the bas...Continue Reading

References

Feb 1, 1978·The American Journal of Psychiatry·J P HoustonM E Jarvik
Jan 1, 1975·Psychopharmacologia·K Andersson
Jan 1, 1987·Psychopharmacology·R Nemeth-CoslettR R Griffiths
Oct 1, 1986·Pharmacology, Biochemistry, and Behavior·W B PickworthJ E Henningfield
Mar 1, 1986·Archives of General Psychiatry·J R Hughes, D Hatsukami
Jan 1, 1984·Journal of Psychosomatic Research·R J West
Jan 1, 1984·Psychopharmacology·S C Peeke, H V Peeke
Sep 1, 1983·Journal of Epidemiology and Community Health·A A AwoteduB O Onadeko
Sep 1, 1983·Psychophysiology·R I HerningJ Bachman
Jan 1, 1983·Neuropsychobiology·K Wesnes, D M Warburton

❮ Previous
Next ❯

Citations

Jan 1, 1995·Medicinal Research Reviews·I P StolermanM Shoaib
Mar 1, 1992·Neuropsychology Review·R L Kane, G G Kay
Jan 1, 1990·Psychopharmacology·I HindmarchN Sherwood
Mar 1, 1995·Psychopharmacology·M E JarvikR E Stein
Jan 1, 1992·Psychopharmacology·P A NewhouseR Lenox
Jan 1, 1993·Psychopharmacology·H S Koelega
Sep 1, 2004·Psychopharmacology·Mohammed Shoaib, Lisiane Bizarro
Jun 6, 2006·Psychopharmacology·Peter S HendricksThomas H Brandon
Oct 1, 1994·Physiology & Behavior·S J KrebsB E Beckwith
Oct 1, 1989·Pharmacology, Biochemistry, and Behavior·S T HigginsJ E Henningfield
Mar 10, 2004·Pharmacology, Biochemistry, and Behavior·Delia C RandallSandra E File
Aug 13, 1998·Pharmacology, Biochemistry, and Behavior·R V FantW B Pickworth
Feb 24, 2011·Experimental and Clinical Psychopharmacology·Bethea A KleykampThomas Eissenberg
Apr 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carol S MyersStephen J Heishman
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·S L BellS J Heishman
Jan 5, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·S J Heishman
Feb 9, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Richard Yi, Reid D Landes
Jul 1, 1997·Addiction·P A MaddenA C Heath
Jan 16, 2007·Molecular Neurobiology·Thomas J Gould
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·M ErnstE D London
Aug 1, 1990·The International Journal of the Addictions·J BrighamM L Stitzer
Feb 7, 2012·Annals of the New York Academy of Sciences·F Scott HallGeorge R Uhl
Dec 22, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Natalie A CeballosSara Jo Nixon
Jan 1, 1994·Journal of Substance Abuse·S ShiffmanM Zettler-Segal
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Delia C RandallSandra E File
Dec 1, 1993·Drug and Alcohol Dependence·S J HeishmanJ E Henningfield
Jun 1, 1989·Drug and Alcohol Dependence·F R SnyderJ E Henningfield
Sep 6, 2005·Pharmacology, Biochemistry, and Behavior·Delia C RandallSandra E File
Jan 1, 1990·The Journal of the American Dental Association·J E Henningfield
Nov 8, 2005·Journal of Psychopharmacology·Delia C RandallSandra E File
Jan 1, 1991·Journal of Psychopharmacology·A C Parrott, G Roberts
Apr 1, 1997·Behavioral Medicine·J Y TsohE Gritz
Oct 12, 2019·Military Medicine·Sean P RoachKenneth L Cameron

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.